Distinct autoimmune syndromes in morphea: A review of 245 adult and pediatric cases

Archives of Dermatology

Volumn 145, Issue 5, 2009, Pages 545-550

  Leitenberger, Justin J ^a   Cayce, Rachael L ^a   Haley, Robert W ^a,b   Adams Huet, Beverley ^a,b   Bergstresser, Paul R ^a,b   Jacobe, Heidi T ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CENTROMERE ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; PHOSPHOLIPID ANTIBODY; SCL 70 ANTIBODY; SMALL NUCLEAR RIBONUCLEOPROTEIN;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CHILD; CLINICAL FEATURE; COMORBIDITY; ETHNIC DIFFERENCE; FAMILY HISTORY; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORPHEA; NEUROLOGIC DISEASE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATIC DISEASE; SCHOOL CHILD; SEX DIFFERENCE;

ADULT; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PREVALENCE; RETROSPECTIVE STUDIES; SCLERODERMA, LOCALIZED; SYNDROME; TEXAS; TIME FACTORS;

EID: 66149108698     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2009.79     Document Type: Article

References (24)

1. González-López MA, Drake M, Gonzalez-Vela MC, Armesto S, Llaca HF, Val-Bernal JF. Generalized morphea and primary biliary cirrhosis coexisting in a male patient. J Dermatol. 2006;33(10):709-713. (Pubitemid 44536378)
2. Khalifa M, Ben Jazia E, Hachfi W, Sriha B, Bahri F, Letaief A. Autoimmune hepatitis and morphea: a rare association. Gastroenterol Clin Biol. 2006;30(6-7):917-918.
3. Dervis E, Acbay O, Barut G, Karaoglu A, Ersoy L. Association of vitiligo, morphea, and Hashimoto's thyroiditis. Int J Dermatol. 2004;43(3):236-237. (Pubitemid 38425678)
4. Parra V, Driban N, Bassotti A. Localized morphea and myasthenia gravis. J Am Acad Dermatol. 2008;49(5):1.
5. Harrington CI, Dunsmore IR. An investigation into the incidence of autoimmune disorders in patients with localized morphoea. Br J Dermatol. 1989;120(5):645-648. (Pubitemid 19143296)
6. Zulian F, Athreya BH, Laxer R, et al; Juvenile Scleroderma Working Group of the Pediatric Rheumatology European Society (PRES). Juvenile localized scleroderma: clinical and epidemiological features in 750 children: an international study. Rheumatology (Oxford). 2006;45(5):614-620.
7. Zulian F, Vallongo C, Woo P, et al; Juvenile Scleroderma Working Group of the Pediatric Rheumatology European Society (PRES). Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum. 2005;52(9):2873-2881.
8. Bonifati C, Impara G, Morrone A, Pietrangeli A, Carducci M. Simultaneous occurrence of linear scleroderma and homolateral segmental vitiligo. J Eur Acad Dermatol Venereol. 2006;20(1):63-65.
9. Majeed M, Al-Mayouf SM, Al-Sabban E, Bahabri S. Coexistent linear scleroderma and juvenile systemic lupus erythematosus. Pediatr Dermatol. 2000;17(6):456-459. (Pubitemid 32039306)
10. Rosenberg AM, Uziel Y, Krafchik BR, et al. Antinuclear antibodies in children with localized scleroderma. J Rheumatol. 1995;22(12):2337-2343.
11. Takehara K, Moroi Y, Nakabayashi Y, Ishibashi Y. Antinuclear antibodies in localized scleroderma. Arthritis Rheum. 1983;26(5):612-616.
12. Falanga V, Medsger TA Jr, Reichlin M. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea. Arch Dermatol. 1987;123(3):350-353. (Pubitemid 17024673)
13. World Health Organization. International Classification of Diseases, Ninth Revision ICD-9. Geneva, Switzerland: World Health Organization; 1977.
14. Okun MR, Edelstein LM, Fisher BK. Gross and Microscopic Pathology of the Skin. 2nd ed. Canton, MA: Dermatopathology Foundation Press; 1988.
15. Vierra E, Cunningham BB. Morphea and localized scleroderma in children. Semin Cutan Med Surg. 1999;18(3):210-225. (Pubitemid 29384283)
16. Census Bureau, Dallas Regional Office. US Census Bureau, 2005-2007 American Community Survey. http://www.census.gov. Accessed February 23, 2009.
17. Spritz RA. The genetics of generalized vitiligo and associated autoimmune diseases. Pigment Cell Res. 2007;20(4):271-278. (Pubitemid 47057312)
18. Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41(5):778-799. (Pubitemid 28225778)
19. Hoffman RW, Greidinger EL. Mixed connective tissue disease. Curr Opin Rheumatol. 2000;12(5):386-390.
20. Jin Y, Mailloux CM, Gowan K, et al. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med. 2007;356(12):1216-1225. (Pubitemid 46465597)
21. Peterson LS, Nelson AM, Su WP, Mason T, O'Fallon WM, Gabriel SE. The epidemiology of morphea (localized schleroderma) in Olmsted County, 1960-1993. J Rheumatol. 1997;24(1):73-80.
22. Wadud MA, Bose BK, Al NT. Familial localised scleroderma from Bangladesh: two case reports. Bangladesh Med Res Counc Bull. 1989;15(1):15-19.
23. Rees RB, Bennett J. Localized scleroderma in father and daughter. AMA Arch Derm Syphilol. 1953;68(3):360.
24. Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. 2nd ed. London, England: Mosby Elsevier; 2008:1469-1484.